MedPath

Blood Gas Analysis and Buffering In Cardiac Arrest

Not Applicable
Completed
Conditions
Cardiac Arrest
Interventions
Registration Number
NCT01362556
Lead Sponsor
Medical University of Graz
Brief Summary

The debate over the administration of sodium bicarbonate in cardiac arrest has been going on for several decades, swinging like a pendulum from "first-line drug" to "not indicated" to the recent guidelines advocating "a small bolus under special conditions (metabolic acidosis, intoxication, long-term resuscitation)". A targeted, blood-gas controlled application under optimised ventilation conditions has not yet been evaluated prehospitally. Our preliminary studies have shown that an arterial puncture/line as well as measurement of blood gases is feasible in preclinical conditions. This multicentre trial including 5 centres and 10 physician-staffed emergency systems is designed to compare, in a prospective randomised controlled study, the effect of a calculated dosage of sodium bicarbonate based on the patientยดs base deficit and weight, on ROSC (= return of spontaneous circulation) and on the secondary survival of cardiac arrest patients. The null hypothesis is that there is no or negative impact on survival.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
700
Inclusion Criteria
  • prehospitally started cardiopulmonary resuscitation (CPR)
  • advanced cardiac life support provided
  • age >18 years
  • arterial pH < 7,2
  • arterial BE < -12
  • arterial pCO2 15-75 mmHg
  • arterial pO2 >35 mmHg
Exclusion Criteria
  • women of childbearing age
  • traumatic cardiac arrest

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sodium ChlorideSodium ChlorideGroup receiving sodium chloride 0.9% after arterial blood gas analysis in cardiac arrest.
Sodium BicarbonateSodium bicarbonateGroup receiving targeted sodium bicarbonate 8% therapy after arterial blood gas analysis in cardiac arrest.
Primary Outcome Measures
NameTimeMethod
Rate of return of spontaneous circulation (ROSC)Within five hours from start of resuscitation.
Secondary Outcome Measures
NameTimeMethod
Survival to discharge after cardiac arrestparticipants will be followed for the duration of hospital stay, an expected average of 5 weeks

Discharge from hospital

Survival after one year of hospital dischargeOne year after event

Trial Locations

Locations (6)

LKH Graz West

๐Ÿ‡ฆ๐Ÿ‡น

Graz, Styria, Austria

Landeskrankenhaus Klagenfurt

๐Ÿ‡ฆ๐Ÿ‡น

Klagenfurt, Carinthia, Austria

Landesklinikum Wiener Neustadt

๐Ÿ‡ฆ๐Ÿ‡น

Wiener Neustadt, Lower Austria, Austria

Landeskrankenhaus Bruck / Mur

๐Ÿ‡ฆ๐Ÿ‡น

Bruck / Mur, Styria, Austria

Medical University Graz

๐Ÿ‡ฆ๐Ÿ‡น

Graz, Styria, Austria

AKH Linz

๐Ÿ‡ฆ๐Ÿ‡น

Linz, Upper Austria, Austria

ยฉ Copyright 2025. All Rights Reserved by MedPath